Does efficient haemodialysis improve the response to hepatitis B virus vaccination?;Poboljšava li učinkovitija hemodijaliza odgovor na cijepljenje protiv virusa hepatitisa B?

Lijecnicki Vjesnik

Volumn 126, Issue 5-6, 2004, Pages 133-137

  Kovačić, Vedran ^a,b   Šain, Milenka ^a   Vukman, Valentina ^a  

^a Dom zdravlja   (Croatia)

^b Dom zdravlja   (Croatia)

Author keywords

Hepatitis B prevention and control; Hepatitis B antibodies blood; Hepatitis B vaccines immunology; Renal dialysis

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE; RECOMBINANT VACCINE; VIRUS ANTIBODY;

ADULT; AGE; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; HEMODIALYSIS; HEPATITIS B; HUMAN; IMMUNE RESPONSE; LEUKOCYTE COUNT; MALE; VACCINATION; BLOOD; HEPATITIS B VIRUS; IMMUNOLOGY; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

ANTIBODIES, VIRAL; FEMALE; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; VACCINES, SYNTHETIC;

EID: 9144240638     PISSN: 00243477     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Hung KY, Chen WY, Yang CS, Lee SH, Wu DJ. Hepatitis B and C in hemodialysis patients. Dial Transplant 1995;24:135-9.
2. Propst T, Propst A, Lhotta K, Vogel W, Konig P. Reinforced intradermal hepatitis B vaccination in hemodialysis patients is superior in antibody response to intramuscular or subcutaneous vaccination. Am J Kidney Dis 1998;32:1041-5.
3. Oesierreicher C, Hammer J, Koch U i sur. HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis. Kidney Int 1995;48:1967-71.
4. Buti M, Viladomiu L, Jardi R i sur. Long-term immunogenicity and efficacy of hepatitis B vaccine in hemodialysis patients. Am J Nephrol 1992; 12:144-7.
5. Johnson DW, Fleming SJ. The use of vaccines in renal failure. Clin Pharmacokinet 1992;22:434-46.
6. Marangi AL, Giordano R, Montanaro A, De Padova F, Schiavone MG, Dongiovanni G. Hepatitis B virus infection in chronic uremia: long-term follow-up of a two-step integrated protocol of vaccination. Am J Kidney Dis 1994;23:537-42.
7. Palmovic D, Crnjakovic-Palmovic J. Vaccination against hepatitis B: Results of the analysis of 2000 population members in Croatia. Eur J Epidemiol 1994;10:541-7.
8. Navarro JF, Teruel JL, Mateos ML, Marcen R, Ortuno J. Antibody level after hepatitis B vaccination in hemodialysis patients: Influence of hepatitis C virus infection. Am J Nephrol 1996;16:95-7.
9. Dumann H, Meyer zum Buschenfelde KH, Kohler H. Hepatitis B vaccination and interleukin-2 receptor expression in chronic failure. Kidney Int 1990;38:1164-8.
10. Girdt M, Kohler H, Schiedhelm-Weick E, Meyer zum Buschenfelde KH, Fleischer B. T cell activation defect in hemodialysis patients: evidence for a role of the B7/CD28 pathway. Kidney Int 1993;44:359-65.
11. Girndt M, Sester M, Sester U, Kaul H, Kohler H. Defective expression of B7-2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect. Kidney Int 2001;59:1382-9.
12. Zannolli R, Morgese G. Hepatitis B vaccine: Current issues. Ann Pharmacother 1997;31:1059-67.
13. National Kidney Foundation - Dialysis Outcome Quality Initiative (NKF-DOQI): Clinical practice guidelines for hemodialysis adequacy. Am J Kidney Dis 1997;30:22-63.
14. Mitwalli A. Responsiveness to hepatitis B vaccine in immunocompromised patients by doubling the dose scheduling. Nephron 1996;73:417-20.
15. Rosman AS, Basu P, Calvin K, Lieber CS. Efficacy of a high and accelerated dose of hepatitis B vaccine in alcoholic patients: A randomized clinical trial. Am J Med 1997;103:217-22.
16. Rault R, Freed B, Nespor S, Bender F. Efficacy of different hepatitis B vaccination strategies in patients receiving hemodialysis. ASAIO J 1996; 41:717-9.
17. Docci D, Cipolloni PA, Mengozzi S, Baldrati L, Capponcini C, Feletti. Immunogenicity of a recombinant hepatitis B vaccine in hemodialysis patients: A two-year follow-up. Nephron 1992;61:352-4.
18. Girndt M, Pietsch M, Kohler H. Tetanus immunization and its association to hepatitis B vaccination in patients with chronic renal failure. Am J Kidney Dis 1995;26:454-60.
19. Stachowski J, Pollok M, Barth C, Maciejewski J, Baldamus CA. Non-responsiveness to hepatitis B vaccination in haemodialysis patients: Association with impaired TCR/CD3 antigen receptor expression regulating co-stimulatory processes in antigen presentation and recognition. Nephrol Dial Transplant 1994;9:144-52.
20. Vlassopoulos D, Arvanitis D, Lilis D, Hatjiyannakos D, Louizou K, Hadjiconslantinou V. Complete success of intradermal vaccination against hepatitis B in advanced chronic renal failure and hemodialysis patients. Renal fail 1997;19:455-60.
21. Fabrizi F, Andrulli S, Bacchini G, Corti M, Locatelli F. Intradermal versus intramuscular hepatitis B re-vaccination in non-responsive chronic dialysis patients: A prospective randomized study with cost-effectiveness evaluation. Nephrol Dial Transplant 1997;12:1204-11.
22. Chang PC, Schrander-van der Meer AM, Van Dorp WT, Van Leer E. Intracutaneous versus intramuscular hepatitis B vaccination in primary non-responding haemodialysis patients. Nephrol Dial Transplant 1996; 11:191-3.
23. Waite NM, Thomson LG, Goldslein MB. Successful vaccination with intradermal hepatitis B vaccine in hemodialysis patients previously nonresponsive to intramuscular hepatitis B vaccine. J Am Soc Nephrol 1995; 5:1930-4.
24. Quiroga JA, Castillo I, Porres JC i sur. Recombinant gamma-interferon as adjuvant to hepatitis B vaccine in hemodialysis patients. Hepatology 1990;12:661-3.
25. Donati D, Gastaldi L. Controlled trial of thymopentin in hemodialysis patients who fail to respond to hepatitis B vaccination. Nephron 1988;50: 133-6.
26. Meuer SC, Dumann H, Buschenfelde KH, Kohler H. Low-dose interleukin-2 induces systemic immune responses against HBsAg in immunodeficient non-responders to hepatitis B vaccination. Lancet 1989;1:15-8.
27. Kapoor D, Aggarwal SR, Singh NP, Thakur V, Sarin SK. Granulocyte- macrophage colony-stimulting factor enhances the efficacy of hepatitis B virus vaccine in previously unvaccinated haemodialysis patients. Viral Hepat 1999;6:405-9.
28. Haubitz M, Ehlerding G, Beigel A, Heuer U, Hemmerling AE, Thoma HA. Clinical experience with a new recombinant hepatitis-B vaccine in previous non-responders with chronic renal insufficiency. Clin Nephrol 1996;45:180-2.
29. Seaworth B, Drucker J, Starling J, Drucker R, Stevens C, Hamilton J. Hepatitis B vaccines in patients with chronic renal failure before dialysis. J Infect Dis 1988;157:332-7.
30. El-Reshaid K, Al-Mufti S, Johny KV, Sugathan TN. Comparison of two immunization schedules with recombinant hepatitis B vaccine and natural immunity acquired by hepatitis B infection in dialysis patients. Vaccine 12:223-8.
31. Fernandez E, Betriu MA, Gomez R, Montoliu J. Response to the hepatitis B virus vaccine in haemodialysis patients: Influence of malnutrition and its importance as a risk factor for morbidity and mortality. Nephrol Dial Transplant 1996;11:1559-63.
32. Khan AN, Bernardini J, Rault RM, Piraino B. Low seroconversion with hepatitis B vaccination in peritoneal dialysis patients. Peritoneal Dial Int 1996;16:370-3.
33. Peces R, De La Tone M, Alcazar R, Urra JM. Prospective analysis of the factor influencing the antibody response to hepatitis B vaccine in hemodialysis patients. Nefrologia 1997;17:73-80 (sažetak).
34. Navarro JF, Teruel JL, Mateos M, Ortuno J. Hepatitis C virus infection decreases the effective antibody response to hepatitis B vaccine in hemodialysis patients. Clin Nephrol 1994;41:113-6.
35. Cheng CH, Huang CC, Leu ML, Chiang CY, Wu MS, Lai PC. Hepatitis B vaccine in hemodialysis patients with hepatitis C viral infection. Vaccine 1994;15:1353-7.
36. Lombardi M, Pizzarelli F, Righi M, Cerrai T, Dattolo P, Nigrelli S. Hepatitis B vaccination in dialysis patients and nutritional status. Nephron 1992; 61:266-8.
37. Skroeder NR, Kjellstrand P, Holmquist B, Nilsson U, Jacobson SH. Increased amounts of C3a and the terminal complement complex at high dialysis blood-flow: The relation with dialysis efficiency. Nephron 1996; 72:523-9.
38. Kimmel PL, Phillips TM, Simmens SJ. Immunologic function and survival in hemodialysis patients. Kidney Int 1998;54:236-44.
39. Girndt M, Sester U, Sester M, Kaul H, Kohler H. Impaired cellular immune function in patients with end-stage renal failure. Nephrol Dial Transplant 1999;14:2807-10.
40. Girndt M, Sester M, Sester U, Kaul H, Kohler H. Molecular aspects of T- and B-cell function in uremia. Kidney Int Suppl 2001;78:S206-11.
41. Hakim RM, Breyer J, Ismail N, Schulman G. Effecets of dose of dialysis on morbidity and mortality. Am J Kidney Dis 1994;23:661-9.
42. Sobh MA, Sheashaa H, Tantawy AEH, Ghoneim MA. Study of effect of optimization of dialysis and protein intake on neuromuscular function in patients under maintance hemodialysis treatment. Am J Nephrol 1998; 18:399-403.
43. Gotch FA. Kt/V is the best dialysis dose parametar. Blood Purif 2000;18: 276-85.
44. Gotch FA, Sargent JA, Keen ML. Whither goest Kt/V? Kidney Int Suppl 2000;76:3-18.